Sort
30,917 grants matching “tumor microenvironment”
Novel mechanisms of B cell tumorigenesis and relapse
$390,930Ping Xie · Rutgers, The State Univ Of N.J. · R01 · FY2024 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
$390,917Pepper J Schedin · Oregon Health & Science University · R01 · FY2020 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
$390,917Pepper J Schedin · Oregon Health & Science University · R01 · FY2021 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$390,879Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2020 · CA
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$390,850Garry P Nolan · Stanford University · U54 · FY2017 · CA
Mechanism of communication between gliomas and glial cells
$390,848Robert M Bachoo · Ut Southwestern Medical Center · R01 · FY2019 · NS
Strategies to improve outcomes for TNBC patients that integrate subtype-specific genomic and immune-based discoveries
$390,826Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2021 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$390,763Trudy Gale Oliver · Duke University · R01 · FY2024 · CA
Mechanisms of linkage of stem and invasive phenotypes during metastatic colonization
$390,738Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · P01 · FY2023 · CA
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2021 · CA
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2020 · CA
Targeting Metabolic Liabilities in Cancer
$390,657Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2022 · CA
Universal Sample Multiplexing for Single Cell Analysis
$390,657Zev Jordan Gartner · University Of California, San Francisco · R33 · FY2023 · CA
Universal Sample Multiplexing for Single Cell Analysis
$390,654Zev Jordan Gartner · University Of California, San Francisco · R33 · FY2022 · CA
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
$390,649Ursula Anne Matulonis · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma
$390,583Gregory B. Lesinski · Emory University · R01 · FY2019 · CA
Project 2: Metabolism-Mediated Changes of Microvesicle Biogenesis
$390,556Richard A. Cerione · Cornell University · U54 · FY2020 · CA
Leaders of Scientific Research Programs
$390,547Peter A Jones · University Of Southern California · P30 · FY2015 · CA
Targeting CXCR2 axis in Pancreatic Cancer
$390,482Rakesh K Singh · University Of Nebraska Medical Center · R01 · FY2019 · CA
Biased chemokine receptor signaling in cancer progression
$390,452Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2020 · CA
Molecular Mechanisms of Initiation of Benign Prostatic Hyperplasia
$390,436Li Xin · University Of Washington · R01 · FY2019 · DK
Exosomes in HNSCC Progression
$390,429Alissa M Weaver · Vanderbilt University · R01 · FY2022 · CA
Synergistic microglial activation and tumor cell killing for improved GBM response
$390,425Vidyalakshmi Chandramohan · Duke University · R01 · FY2024 · NS
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
$390,425Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
Innate Antiviral Signals for Cancer Immunotherapy
$390,425Matthias Gromeier · Duke University · R01 · FY2024 · NS